Article Type
Article
Changed
Thu, 09/19/2019 - 13:55
Display Headline
Perspectives on Rheumatoid Arthritis for the Orthopedic Surgeon: Overview of Non-Tumor Necrosis Factor Biologic Drugs and Perioperative Management
Author(s)
Keith MP

Article PDF
040120272.pdf
Author and Disclosure Information

Michael P. Keith, MD

Issue
The American Journal of Orthopedics - 40(12)
Publications
The American Journal of Orthopedics
MDedge Surgery
Topics
Rheumatology
Shoulder & Elbow
Musculoskeletal Disorders
Orthopedics
Page Number
E272-E275
Legacy Keywords
rheumatoid arthritis; biologics; disease modifying antirheumatic drug, DMARD, rituximab; abatacept; tocilizumab; surgical site infection; perioperative; Perspectives on Rheumatoid Arthritis for the Orthopedic Surgeon: Overview of Non-Tumor Necrosis Factor Biologic Drugs and Perioperative Management; Michael P. Keith; The American Journal of Orthopedics, AJO
Author(s)
Keith MP
Author(s)
Keith MP
Author and Disclosure Information

Michael P. Keith, MD

Author and Disclosure Information

Michael P. Keith, MD

Article PDF
040120272.pdf
Article PDF
040120272.pdf

Issue
The American Journal of Orthopedics - 40(12)
Issue
The American Journal of Orthopedics - 40(12)
Page Number
E272-E275
Page Number
E272-E275
Publications
The American Journal of Orthopedics
MDedge Surgery
Publications
The American Journal of Orthopedics
MDedge Surgery
Topics
Rheumatology
Shoulder & Elbow
Musculoskeletal Disorders
Orthopedics
Article Type
Article
Display Headline
Perspectives on Rheumatoid Arthritis for the Orthopedic Surgeon: Overview of Non-Tumor Necrosis Factor Biologic Drugs and Perioperative Management
Display Headline
Perspectives on Rheumatoid Arthritis for the Orthopedic Surgeon: Overview of Non-Tumor Necrosis Factor Biologic Drugs and Perioperative Management
Legacy Keywords
rheumatoid arthritis; biologics; disease modifying antirheumatic drug, DMARD, rituximab; abatacept; tocilizumab; surgical site infection; perioperative; Perspectives on Rheumatoid Arthritis for the Orthopedic Surgeon: Overview of Non-Tumor Necrosis Factor Biologic Drugs and Perioperative Management; Michael P. Keith; The American Journal of Orthopedics, AJO
Legacy Keywords
rheumatoid arthritis; biologics; disease modifying antirheumatic drug, DMARD, rituximab; abatacept; tocilizumab; surgical site infection; perioperative; Perspectives on Rheumatoid Arthritis for the Orthopedic Surgeon: Overview of Non-Tumor Necrosis Factor Biologic Drugs and Perioperative Management; Michael P. Keith; The American Journal of Orthopedics, AJO
Article Source

PURLs Copyright

Inside the Article

Article PDF Media